Navigation Links
Molecular probe 'paints' cancer cells in living animals, Stanford researchers find
Date:9/9/2007

STANFORD, Calif. - Researchers at the Stanford University School of Medicine have developed a molecular probe that sets aglow tumor cells within living animals. Their goal is to use the probe to improve the diagnosis and treatment of cancer and other diseases.

The probe's main ingredient is a molecule that labels active proteases - protein-destroying enzymes - that run amok in cancerous cells. The molecule is normally invisible to the naked eye but it carries a fluorescent tag that lights up when it binds to the protease. The tag beams out near-infrared light that passes through skin and is detectable with a special camera. The use of the imaging technique in mice is described in a study to be published in the Sept. 9 advance online issue of Nature Chemical Biology.

"Nowadays the detection of cancer, breast cancer for instance, is normally done by mammography, using X-rays - which might actually increase your risk of cancer. We think these probes may ultimately provide a less harmful, noninvasive method of detecting cancer," said the article's lead author Galia Blum, PhD, a postdoctoral scholar in the laboratory of Matthew Bogyo, PhD, assistant professor of pathology.

And that's just for starters.

"It's neat. The next generation of our experiments will apply the probes during surgery," said Bogyo, the study's senior author. "It would be nice to 'paint' it on tissues so you could distinguish between tumor and non-tumor."

A key advantage of this enzyme-targeting molecule is its size. About 100 times smaller than other molecular imaging reporters, it can easily slip across the cell membrane and enter living cells. It can also move through the animal quickly, which opens up the possibility of using the technique to light up tumors while surgery is in progress.

"Unlike other enzyme-targeting molecules, it's very specific, sticks to where it binds and does it all very rapidly - in 30 minutes or less," Bogyo sai
'/>"/>

Contact: Rosanne Spector
manishma@stanford.edu
650-725-5374
Stanford University Medical Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Molecular markers for early diagnosis of breast and ovarian cancer
2. Scientists Developed Map For Brain Molecular Communities
3. Molecular Mechanism Of HIV Infecting The Healthy Cells Discovered.
4. Molecular Flaw Detected in Aggressive Breast Cancers
5. Molecular Computer Developed To perform Calculations From Within Human Body
6. Lung cancer molecular profile discovered by researchers.
7. Molecular Imaging Of Cancer Now Possible, New Hybrid Virus Produced
8. Molecular Basis Of ALS Found
9. New Molecular Treatment Identified To Treat Blood Cell Cancers
10. Researchers Find Molecular "Brake" to Cell Death
11. Solitons Could Power Molecular Electronics, Artificial Muscles

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...AM,Ala.,Nov.24/PRNewswire-FirstCall/--HealthSouthC...ateintheBankofAmericaMerrillLynch2009CreditConfere...rVicePresidentandTreasurerEdFaywillbespeakingonThu...ewebcastliveandwillbeavailableat http://investor.h... AboutHealthSouth ,, HealthSouthisthenation,sl...
(Date:11/24/2009)...at pose choking hazard, are too loud, or contain d...(HealthDay News) -- As the holiday shopping season...toys are still being sold in stores across the Uni... annual Trouble in Toyland report, released Tues...RG). , The report focuses on toys that pose a c...
(Date:11/24/2009)...ibutes to the falls that plague older adults, stud...y News) -- Falls are a leading cause of death amon...chronic pain contributes to those accidents. , ... weakness, and is associated with mobility limitat...hors wrote. , "Chronic pain, no matter how we m...
(Date:11/24/2009)...n example, study finds no added use but higher cos... -- Direct-to-consumer drug ads may contribute to ...at examined sales of the widely used antiplatelet ...ta from 1999 to 2005 for 27 state Medicaid program...opidogrel did not increase people,s use of the dru...
(Date:11/24/2009)...Nov.24/PRNewswire-USNewswire/--Thereisanewgameinto...reduction,offeringpragmaticandrealisticstrategiesw...ed.SpearheadingthismovementisagroupcalledHAMS--Har...AMSisafree-of-charge,lay-ledsupportandinformationa...nstituteonAlcoholAbuseandAlcoholismtellsusthatonly...
Breaking Medicine News(10 mins):Health News:Dangerous Toys Still on Store Shelves, Report Finds 2Health News:Dangerous Toys Still on Store Shelves, Report Finds 3Health News:Chronic Pain Trips Up Seniors 2Health News:Chronic Pain Trips Up Seniors 3Health News:Advertising to Consumers May Raise Drug Prices 2Health News:Harm Reduction for Alcohol: An Idea Whose Time Has Arrived 2
...ernors and Mayors Support Event, ALEXANDRIA, Va.,...ealthcare Decisions Day (NHDD), will be the larges... professionals about,advance healthcare planning.,...are Decisions Day. "All Americans should use April...
...hm-Stecher, assistant professor in food science an... with tiny particles. His latest research project ...ver nanoparticles to improve the safety of the wor...such as microbe-resistant fabrics or non-biofoulin...
...il 10 Hooper Holmes,(Amex: HH ) today announced ... Chief Executive Officer and that Benjamin A. Curr...ctors. Mr. Bubbs, who has been a member of the,Boa...usly been named Chairman-Elect,continues as Chairm...
...fied opinion in Type II examination by independent...LLE, Colo., April 10 GHX has received an,unqualif...of its first Type,II SAS 70 compliance audit. The ...ed GHX,s exchange services, which,enable more than...
...y David Spiegel of Faculty of 1000 Medicine ( www....ween depression care management and survival rates...nt and well-conducted study of the effects of trea... sciences at Stanford University, Spiegel evaluate...
...ntries for the eighth,annual Michael E. DeBakey Jo...iomedical Research (FBR) and named after FBR,s cha...s open to all professional journalists whose repor...Dr. DeBakey,s many inventions and innovations have...
Other Medicine News:Health News:National Healthcare Decisions Day in All 50 States, DC, Puerto Rico, and Internationally 2Health News:Iowa State University researcher looks to use nanoparticles for food safety 2Health News:Hooper Holmes Names Roy Bubbs President and CEO, Benjamin Currier Continues as Chairman 2Health News:Hooper Holmes Names Roy Bubbs President and CEO, Benjamin Currier Continues as Chairman 3Health News:GHX Achieves SAS 70 Compliance 2Health News:DeBakey Awards to Recognize Excellence in Biomedical Research Journalism 2
(Date:11/24/2009)...rstCall/--NeurocrineBiosciences,Inc.(Nasdaq: NBIX ...ecutiveOfficerofNeurocrineBiosciences,willbepresen...einNewYork. ,, ThelivepresentationtakesplaceTue....m.PacificTime(PT).Thepresentationwillbesimultaneo... http://www.neurocrine.com . ,, Ifyouareunablet...
(Date:11/24/2009)...Newswire/--SatelliteHealthcare,oneofthenation,sfir...ajorsponsorofnephrologyresearch,todayannounceditsf...lahinhisefforttosupporttheSanJosehomelessthisThank...ulcareerasachefforthepast20years.ButNasrallah,slif...edwithEndStageRenalDisease(ESRD).Thediagnosisirrev...
(Date:11/24/2009)...rstCall/--Orexigen®Therapeutics,Inc.(Nasdaq: ...entofobesity,todayannouncedthatonNovember18,2009th...rsgrantedaninducementstockoptiontopurchase200,000s...pointedHeadoftheGlobalContraveProgram. ,, Thest...extentpermittedbylawandhasanexercisepricepersharee...
Breaking Medicine Technology:Satellite Healthcare and Renal Disease Survivor Elias Nasrallah Join Forces to Support the Homeless This Holiday Season 2Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) 2Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) 3Fate Therapeutics Closes 2430 Million Series B Financing 14844 1Fate Therapeutics Closes 2430 Million Series B Financing 14844 2Fate Therapeutics Closes 2430 Million Series B Financing 14844 3Fate Therapeutics Closes 2430 Million Series B Financing 14844 4Sleep Management Device Unit Sales to Grow at a Compound Annual Growth Rate of Over 16 25 as CMS Reimbursement Expands 6280 1Sleep Management Device Unit Sales to Grow at a Compound Annual Growth Rate of Over 16 25 as CMS Reimbursement Expands 6280 2Sleep Management Device Unit Sales to Grow at a Compound Annual Growth Rate of Over 16 25 as CMS Reimbursement Expands 6280 3China Medicine Announces Strong Third Quarter 2009 Results 6275 1China Medicine Announces Strong Third Quarter 2009 Results 6275 2China Medicine Announces Strong Third Quarter 2009 Results 6275 3China Medicine Announces Strong Third Quarter 2009 Results 6275 4China Medicine Announces Strong Third Quarter 2009 Results 6275 5China Medicine Announces Strong Third Quarter 2009 Results 6275 6China Medicine Announces Strong Third Quarter 2009 Results 6275 7China Medicine Announces Strong Third Quarter 2009 Results 6275 8China Medicine Announces Strong Third Quarter 2009 Results 6275 9China Medicine Announces Strong Third Quarter 2009 Results 6275 10China Medicine Announces Strong Third Quarter 2009 Results 6275 11China Medicine Announces Strong Third Quarter 2009 Results 6275 12China Medicine Announces Strong Third Quarter 2009 Results 6275 13China Medicine Announces Strong Third Quarter 2009 Results 6275 14China Medicine Announces Strong Third Quarter 2009 Results 6275 15
...., May 9 /PRNewswire-FirstCall/ -- Wyeth (NYSE: WY...inistration,s (FDA),San Juan District Office has i...ion of its Guayama, Puerto Rico manufacturing,faci... of the site.,The new classification means that an...ed by the Company or do not merit any further,regu...
...taminated with Diethylene Glycol,(DEG) Remains a P..., Md., May 4, 2007-The U.S. Food and Drug,Administ...rs,suppliers, drug repackers, and health professi...gilant in assuring that glycerin, a,sweetener comm...,prescription drug products, is not contaminated w...
Other Medicine Technology:FDA Re-Inspection Results in Positive Re-Classification of Guayama,Facility 2FDA Re-Inspection Results in Positive Re-Classification of Guayama,Facility 3FDA Advises Manufacturers to Test Glycerin for Possible,Contamination 2
511 Lightweight Pneumatic Conserver
...Conserver., ,Offers an average 5:1 increase in us...standard cannula. , ,The combination of the OXYMA...ulatory oxygen patients a superior alternative to ...warranty. , ,NOTE: Each model has passed the ...
WAVE 6203
...afts For Insertion Through A 1.0mm Incision., ,... Improved Ergonomics., ,Curved Shafts F...s For Improved Sub-Incisional Flap Purchase., ,...ring Sterilization., ,Reusable, Autoclaveable,...
Medicine Products: